Experts Doubt Kennedy’s Timetable for Finding the Cause of Autism
The nation’s health secretary announced that he planned to invite scientists to provide answers by September, but specialists consider that target date unrealistic.
It Is Happening Every Day, Every Where
The nation’s health secretary announced that he planned to invite scientists to provide answers by September, but specialists consider that target date unrealistic.
Two significant programs that invested in research on diabetes, dementia, obesity and kidney disease have ended since the start of the Trump administration.
The decision came as an initial win for a broad coalition of academic institutions that had argued the policy jeopardized ongoing research, but it set up an almost certain appeal.
An attorney general in one of those states said the Trump administration was upending “the promise of progress for future generations.”
Trump cutbacks were supposedly aimed at administrators. But scientists in food and drug-testing labs and policy experts who advance generic drug approvals were also dismissed.
Since World War II, U.S. research funding has led to discoveries that fueled economic gains. Now cutbacks are seen as putting that legacy in jeopardy.
Federal officials cited the end of the Covid-19 pandemic in halting the research. But much of the work was focused on preventing outbreaks of other pathogens.
Children’s Health Defense, founded by the health secretary, had published online a vaccine-safety page that looked like the agency’s but that suggested links to autism.
After the Dobbs decision, births rose in states with bans, but more for some women than others.
About 19 positions will be cut, including those in offices focused on technology policy and diversity, equity and inclusion.